IN Iskandar Puteri, three of Malaysia’s biggest private hospital groups are betting on the same market.
Asia OneHealthcare Bhd (A1H) plans to add 186 beds to its Columbia Asia hospital, Sunway Healthcare Holdings Bhd is building a 410-bed hospital, and IHH Healthcare Bhd is expanding its Gleneagles Hospital Johor campus.
Across Malaysia, private hospital bed capacity grew by 3.8% a year from 2020 to 2024, outpacing the 3% annual rise in inpatient admissions, according to industry research published in A1H’s draft prospectus.
At IHH’s Malaysian hospitals, data for its domestic market segment may indicate an early moderation as its plan to focus capital expenditure on ambulatory care gathers steam.
According to data from IHH, admissions in Malaysia rose 2.5% in 2025 from the previous year, even as the average stay shortened from 2.9 to 2.7 days and occupancy fell from 70% to 63%.
IHH notes that its occupancy rate may be lower due to new hospitals that are in the ramp-up stage. Nevertheless, average revenue per inpatient admission in Malaysia saw a 7.3% year-on-year rise to RM11,441.
As more beds come on stream in the private healthcare ecosystem in Malaysia and the region, the question in Iskandar Puteri and elsewhere is whether patients will spend enough nights in those wards for operators to cover the cost of staffing them and earn a return on what they had spent building them.
BIMB Securities Research healthcare analyst Maliana Shaharudin sees a localised risk of oversupply.
“The key concern is the concentration of new private hospital capacity in established urban markets, particularly the Klang Valley and Johor, where operators are competing for similar patient demographics, specialists and insured populations,” she tells StarBiz 7.
“We believe a more meaningful risk is a mismatch between where new beds are being added and where healthcare demand remains underserved.
“Secondary cities may offer opportunities for expansion, but affordability, insurance penetration and specialist availability remain important considerations,” Maliana says.
KPJ Healthcare Bhd has the biggest disclosed expansion programme of the four, with about 2,200 additional beds planned under its five-year strategy and a target of around 6,000 beds by 2030. The group is expanding existing hospitals, including sites in Johor, Klang and Kuching.
Sunway Healthcare is the most aggressive in terms of its growth plans with an expected 3,455 additional beds by 2032, about 67% above its mid-2026 capacity. A1H is targeting about 3,900 built beds across Malaysia and Vietnam by March 2032, while IHH aims for more than 4,000 beds in Malaysia by 2030.
Operators can still choose to stagger openings as demand builds.
A1H’s draft prospectus shows it had 2,951 built beds in Malaysia at its cut-off date, of which 2,539 were licensed.
Sunway Healthcare says it will license the 216 additional beds in its new tower at Sunway Medical Centre Sunway City in phases.
“We believe competition for specialists and nurses could become more intense than competition for physical bed capacity,” says Maliana.
“Malaysia already faces a shortage of nearly 11,000 medical specialists across the public and private sectors. This creates two implications.
“First, new hospitals may struggle to ramp up utilisation without an established specialist base. Second, competition for experienced consultants could increase recruitment costs and pressure margins.
“Ultimately, we believe doctors attract patients, rather than additional beds attracting doctors,” she adds.
Bed occupancy already varies widely. A1H’s group occupancy fell from 67.7% to 65.3% in the financial year ended March 31, 2026, with its newer Batu Kawan hospital at 39.3%.
Sunway Healthcare’s occupancy rose from 67.4% to 72.8% in the second quarter of 2026 even as its licensed bed count expanded 12.6% year-on-year.
“There is no universal break-even occupancy rate, as profitability depends on a hospital’s case mix, average revenue per patient, staffing costs and operating efficiency,” Maliana says.
“As a general industry benchmark, 60%-70% bed occupancy represents a reasonable operating target for established private hospitals, although this should not be confused with a guaranteed break-even threshold.
“Consequently, a hospital operating at 50% occupancy can still be profitable if it handles high-value procedures, while another operating at 70% may struggle if its revenue intensity is low or cost structure is inefficient,” she adds.
Medical tourism can help fill some wards.
Malaysia drew about 1.84 million healthcare travellers and generated RM3.34bil in healthcare revenue in 2025. Preliminary figures
for the first half of 2026 put
revenue at RM1.74bil from
about 889,000 arrivals.
“Established medical tourism destinations such as Penang, Kuala Lumpur and Johor are better positioned to capture foreign patients, particularly hospitals with recognised specialists and established international referral networks,” Maliana says.
“Furthermore, healthcare traveller numbers include outpatient consultations, health screenings and other services that do not necessarily translate into inpatient admissions or bed occupancy.”
Amid these dynamics, MediAsas could also help widen the domestic pool of insured patients.
RHB Research expects take-up to be gradual after the basic medical insurance and takaful plan launches nationwide in January 2027.
The initial payment model combines itemised charges with a preset rate for each treatment category under diagnosis-related group payments.
That gives participating hospitals a financial incentive to manage treatment costs and the length of stays.
“Medical tourism should, therefore, be viewed as a supplementary growth driver rather than a substitute for sustainable domestic demand.
“Hospitals that rely excessively on foreign patients to justify expansion may face greater earnings volatility from regional competition, currency movements and geopolitical developments,” Maliana says.
In private hospital expansion, it would appear that the key to determining future success is how many beds each operator puts into service, how many nights patients spend in them and what it costs to keep those wards open.
How new demand will actually be created will also be key, as artificial intelligence eventually brings dramatic advances in the healthcare and pharmaceutical space with potentially lower costs due to drastically reduced development times in the latter.